Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia

British Journal of Pharmacology

Volumn 146, Issue 4, 2005, Pages 498-505

  Collin, Marika ^a   Anuar, Farhana B M ^b   Murch, Oliver ^a   Bhatia, Madhav ^b   Moore, Philip K ^b   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CSE; Cystathionine lyase; DL propargylglycine; Hydrogen sulfide; LPS; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM LIPOPOLYSACCHARIDE; BIOLOGICAL MARKER; CREATINE KINASE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; LYASE INHIBITOR; MYELOPEROXIDASE; PROPARGYLGLYCINE; SODIUM CHLORIDE; TRIACYLGLYCEROL LIPASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTOXEMIA; ENZYME ACTIVITY; ESCHERICHIA COLI; HEART ARREST; HYPOTENSION; LIVER CELL DAMAGE; LIVER INJURY; MALE; NEUROMUSCULAR DISEASE; NONHUMAN; ORGAN INJURY; PANCREAS INJURY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TACHYCARDIA;

ALANINE TRANSAMINASE; ALKYNES; ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; CHEMOTAXIS, LEUKOCYTE; CREATINE KINASE; CYSTATHIONINE BETA-SYNTHASE; CYSTATHIONINE GAMMA-LYASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; GLYCINE; HEART RATE; HYDROGEN SULFIDE; LIPASE; LIPOPOLYSACCHARIDES; LIVER; MALE; MULTIPLE ORGAN FAILURE; PANCREAS; PEROXIDASE; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS;

EID: 27144558325     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706367     Document Type: Article

References (32)

1. ABE, K. & KIMURA, H. (1996). The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci., 16, 1066-1071.
2. BAUE, A.E. (1999). Sepsis, multi-organ dysfunction syndrome (MODS) and multiple organ failure (MOF). Prevention is better than treatment. Minerva Anestesiol., 65, 477-480.
3. BAUE, A.E. (1993). The multiple organ or system failure syndrome. In: Pathophysiology of Shock, Sepsis, and Organ Failure, ed. Schlag, G. & Redl, H. pp. 1004-1008. Berlin: Springer Verlag.
4. BHATIA, M., BRADY, M., ZAGORSKI, J., CHRISTMAS, S.E., CAMPBELL, F., NEOPTOLEMOS, J.P. & SLAVIN, J. (2000). Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut, 47, 838-844.
5. BHATIA, M., SALUJA, A.K., HOFBAUER, B., FROSSARD, J.L., LEE, H.S., CASTAGLIUOLO, I., WANG, C.C., GERARD, N., POTHOULAKIS, C. & STEER, M.L. (1998). Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc. Natl. Acad. Sci. U.S.A., 95, 4760-4765.
6. BHATIA, M., SIDHAPURIWALA, I., MOOCHHALA, S.M. & MOORE, P.K. (2005a). Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat. Br. J. Pharmacol., 145, 141-144.
7. BHATIA, M., WONG, F.L., FU, D., LAU, H.Y., MOOCHHALA, S.M. & MOORE, P.K. (2005b). Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J., 19, 623-625.
8. CHEN, P., PODDAR, R., TIPA, E.V., DIBELLO, P.M., MORAVEC, C.D., ROBINSON, K., GREEN, R., KRUGER, W.D., GARROW, T.A. & JACOBSEN, D.W. (1999). Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv. Enzyme Regul., 39, 93-109.
9. CHENG, Y., NDISANG, J.F., TANG, G., CAO, K. & WANG, R. (2004). Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am. J. Physiol. Heart Circ. Physiol., 287, H2316-H2323.
10. CHUNYU, Z., JUNBAO, D., DINGFANG, B., HUI, Y., XIUYING, T. & CHAOSHU, T. (2003). The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem. Biophys. Res. Commun., 302, 810-816.
11. GENG, B., YANG, J., QI, Y., ZHAO, J., PANG, Y., DU, J. & TANG, C. (2004). H2S generated by heart in rat and its effects on cardiac function. Biochem. Biophys. Res. Commun., 313, 362-368.
12. HEWETT, J.A., JEAN, P.A., KUNKEL, S.L. & ROTH, R.A. (1993). Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury. Am. J. Physiol., 265, G1011-G1015.
13. HOSOKI, R., MATSUKI, N. & KIMURA, H. (1997). The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun., 237, 527-531.
14. HUI, Y., DU, J., TANG, C., BIN, G. & JIANG, H. (2003). Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats. J. Infect., 47, 155-160.
15. JAESCHKE, H., FARHOOD, A. & SMITH, C.W. (1991). Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am. J. Physiol., 261, G1051-G1056.
16. JOHNSTON, M., JANKOWSKI, D., MARCOTTE, P., TANAKA, H., ESAKI, N., SODA, K. & WALSH, C. (1979). Suicide inactivation of bacterial cystathionine gamma-synthase and methionine gammalyase during processing of L-propargylglycine. Biochemistry, 18, 4690-4701.
17. KIMURA, H. (2002). Hydrogen sulfide as a neuromodulator. Mol. Neurobiol., 26, 13-19.
18. KLINTMAN, D., SCHRAMM, R., MENGER, M.D. & THORLACIUS, H. (2002). Leukocyte recruitment in hepatic injury: selectin-mediated leukocyte rolling is a prerequisite for CD18-dependent firm adhesion. J. Hepatol., 36, 53-59.
19. LI, L., BHATIA, M., ZHU, Y.Z., ZHU, Y.C., RAMNATH, R.D., WANG, Z.J., ANUAR, F.B., WHITEMAN, M., SALTO-TELLEZ, M. & MOORE, P.K. (2005). Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J., 19, 1196-1198.
20. MILLAR, C.G. & THIEMERMANN, C. (2002). Carboxy-PTIO, a scavenger of nitric oxide, selectively inhibits the increase in medullary perfusion and improves renal function in endotoxemia. Shock, 18, 64-68.
21. MOK, Y.Y., SHIRHAN BIN MOHAMMED, A.M., YOKE, P.C., ZHONG, J.W., BHATIA, M., MOOCHHALA, S. & MOORE, P.K. (2004). Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br. J. Pharmacol., 143, 881-889.
22. MOORE, P.K., BHATIA, M. & MOOCHHALA, S. (2003). Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol. Sci., 24, 609-611.
23. QINGYOU, Z., JUNBAO, D., WEIJIN, Z., HUI, Y., CHAOSHU, T. & CHUNYU, Z. (2004). Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem. Biophys. Res. Commun., 317, 30-37.
24. RUETTEN, H., SOUTHAN, G.J., ABATE, A. & THIEMERMANN, C. (1996). Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br. J. Pharmacol., 118, 261-270.
25. RUETTEN, H. & THIEMERMANN, C. (1997). Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase. Br. J. Pharmacol., 122, 59-70.
26. STIPANUK, M.H. & BECK, P.W. (1982). Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J., 206, 267-277.
27. TANAKA, Y., KOBAYASHI, K., TAKAHASHI, A., ARAL, I., HIGUCHI, S., OTOMO, S., HABU, S. & NISHIMURA, T. (1993). Inhibition of inflammatory liver injury by a monoclonal antibody against lymphocyte function-associated antigen-1. J. Immunol., 151, 5088-5095.
28. TEAGUE, B., ASIEDU, S. & MOORE, P.K. (2002). The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br. J Pharmacol., 137, 139-145.
29. UREN, J.R., RAGIN, R. & CHAYKOVSKY, M. (1978). Modulation of cysteine metabolism in mice - effects of propargylglycine and L-cyst(e)ine-degrading enzymes. Biochem. Pharmacol., 27, 2807-2814.
30. 2S be the third endogenous gaseous transmitter? FASEB J., 16, 1792-1798.
31. 2S in rat tissues. Can. J. Physiol. Pharmacol., 81, 848-853.
32. ZHAO, W., ZHANG, J., LU, Y. & WANG, R. (2001). The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J., 20, 6008-6016.